2026-09-292026-09-29https://scholars.csmu.edu.tw/handle/123456789/19368Lung cancer mortality was 1.7 million in 2015, which accounted for 19.2% of total cancer death. The five year survival rate of NSCLC is about 47% for Stage I, 30% for stage II cancer,14% for stage...(詳)在2015年全世界有170萬人死於肺癌, 約占癌症死亡人數的19.2%。非小細胞肺癌五年的存活率約為: 第I期47%，第II期30%，第IIIA期14%，第IIIB期5%，第IV期只有1%。然...(詳)胜肽藥物肺癌抑制生長抑制侵犯Peptide druglung cancergrowth inhibitioninvasion inhibitionProject